CymaBay Therapeutics (NASDAQ:CBAY) Reaches New 52-Week High

Shares of CymaBay Therapeutics, Inc. (NASDAQ:CBAY – Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $25.72 and last traded at $24.89, with a volume of 549844 shares traded. The stock had previously closed at $24.00. Analyst Ratings Changes CBAY has been the subject […]

Related Keywords

China , Piper Sandler , Pault Quinlan , Raymond James , William Blair , Charles Mcwherter , Nasdaq , Great West Life Assurance Co , Wetzel Investment Advisors Inc , Securities Exchange Commission , Harvest Fund Management Co , Cymabay Therapeutics Company Profile , Cymabay Therapeutics Inc , China Universal Asset Management Co , Cymabay Therapeutics , Get Free Report , Bay Therapeutics , General Counsel Paul , Exchange Commission , Fund Management , Universal Asset Management , Investment Advisors , Great West Life Assurance , Cymabay Therapeutics Daily , Nasdaq Cbay , Cbay , Medical , Stocks , Technicals ,